We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $3.11B
1-Year Est. Return 94.93%
This Fund
S&P 500
This Quarter Est. Return
+18.98%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$1.11B
AUM Growth
-$9.62M
Cap. Flow
-$119M
Cap. Flow %
-10.78%
Top 10 Hldgs %
93%
Holding
18
New
–
Increased
3
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$106M
2
NMRK icon
Newmark Group
NMRK
+$13M
3
NG icon
NovaGold Resources
NG
+$4.94M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$243M

Sector Composition

Rank Sector Weight
1 Healthcare 42.23%
2 Materials 34.94%
3 Financials 15.48%
4 Technology 3.67%
5 Real Estate 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.4B
$256M 23.09%
1,105,741
+605,741
+121% +$106M
BHC icon
2
Bausch Health
BHC
$1.69B
$212M 19.14%
26,439,035
– –
AAMI
3
Acadian Asset Management
AAMI
$2.94B
$171M 15.48%
8,950,121
– –
NG icon
4
NovaGold Resources
NG
$2.55B
$88M 7.95%
23,541,483
+1,315,183
+6% +$4.94M
PPTA
5
Perpetua Resources
PPTA
$2.18B
$78.5M 7.09%
24,771,542
– –
AU icon
6
AngloGold Ashanti
AU
$39.9B
$71.6M 6.47%
3,833,492
– –
AEM icon
7
Agnico Eagle Mines
AEM
$71.9B
$43M 3.88%
783,561
– –
THRY icon
8
Thryv Holdings
THRY
$184M
$40.7M 3.67%
2,000,000
– –
THM
9
International Tower Hill Mines
THM
$500M
$36.2M 3.27%
61,930,724
– –
NMRK icon
10
Newmark Group
NMRK
$2.88B
$32.9M 2.97%
3,000,000
+1,715,375
+134% +$13M
SA
11
Seabridge Gold
SA
$2.69B
$25.1M 2.27%
2,070,000
– –
SSRM icon
12
SSR Mining
SSRM
$5.27B
$21.5M 1.94%
2,000,000
– –
EQX icon
13
Equinox Gold
EQX
$7.22B
$12.2M 1.1%
2,500,000
– –
TMQ
14
Trilogy Metals
TMQ
$517M
$6.16M 0.56%
14,326,996
– –
IAG icon
15
IAMGOLD
IAG
$8.24B
$4.68M 0.42%
1,850,000
– –
TELL
16
DELISTED
Tellurian Inc.
TELL
$4.04M 0.36%
5,340,663
– –
BABA icon
17
Alibaba
BABA
$276B
$3.88M 0.35%
50,000
– –
HZNP
18
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-2,103,046
Closed -$243M

Similar funds

TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Paulson & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Paulson & Co held 18 positions worth $1.11B, down 0.86% from $1.12B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Paulson & Co withdrew a net $119M in Q4 2023, closing 1 position. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $243M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 48% a quarter earlier, followed by Materials and Financials.

Against the trend, Paulson & Co added an estimated $106M to Madrigal Pharmaceuticals.

  • Paulson & Co added most to Madrigal Pharmaceuticals in Q4 2023, an estimated $106M increase.
  • Paulson & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $243M.
  • Paulson & Co's ten largest holdings make up 93% of its $1.11B portfolio in Q4 2023.
  • Paulson & Co opened 0 new positions and closed 1 in Q4 2023.
  • Paulson & Co's portfolio value fell 0.86% quarter-over-quarter to $1.11B.

Based on Paulson & Co's 13F filing for Q4 2023, filed 14 Feb 2024.